Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

4. PSICOFARMACOLOGÍA DE LA DEPENDENCIA DE LAS DIFERENTES CLASES DE DROGASTramer MR y colab. (2001) Cannabinoids for control of chemotherapy inducednausea and vomiting: quantitative systematic review. British Medical Journal,323:16-21.Tyndale RF, Sellers EM (2001) Variable CYP2A6-mediated nicotine metabolismalters smoking behavior and risk. Drug Metabolism and Disposition, 29:548–552.Uchtenhagen A y colab. (1999) Prescription of narcotics for heroin addicts: mainresults of the Swiss national cohort study. Basilea, Suiza.Ujike H (2002) Stimulant-induced psychosis and schizophrenia: the role of sensitization.Current Psychiatry Reports, 4:177–184.UNODCP (2002) Amphetamine-type stimulants threaten East Asia. ODCCPUpdate, Marzo 2002:Departamento de Salud y Servicios Humanos de Estados Unidos (1988) The healthconsequences of smoking: nicotine addiction. A report of the Surgeon General.Washington, DC, Oficina de Impresiones Gubernamentales de EE.UU.Vaccarino AL, Kastin AJ (2001) Endogenous opiates: 2000. Peptides, 22:2257–2328.Van den Brink y colab. (2002) Medical co-prescription of heroin: two randomizedcontrolled trials. Report to Government. Utrecht, Holanda, Comité CentralCentral para el Tratamiento de Adictos a la Heroína (disponible en la página deInternet en http://www.ccbh.nl).Van Ree JM, Gerrits MA, Vanderschuren LJ (1999) Opioids, reward and addiction:an encounter of biology, psychology and medicine. PharmacologicalReviews, 51:341–396.Verebey K, Alrazi J, Jafre JH (1988) The complications of "Ecstasy" (MDMA).Journal of the American Medical Association, 259:1649–1650.Vidal C (1996) Nicotinic receptors in the brain: molecular biology, function,and therapeutics. Molecular Chemistry and Neuropathology, 28:3–11.Vogel-Sprott M, Sdao-Jarvie K (1989) Learning alcohol tolerance: the contributionof response expectancies. Psychopharmacology, 98:289–296.Volkow ND, Fowler JS (2000) Addiction, a disease of compulsion and drive:involvement of the orbitofrontal cortex. Cerebral Cortex, 10:318–325.Volkow ND y colab. (1996) Cocaine addiction: hypothesis derived from imagingstudies with PET. Journal of Addictive Diseases, 15:55–71.Volkow ND y colab. (1999) Reinforcing effects of psychostimulants in humansare associated with increases in brain dopamine and occupancy of D2 receptors.Journal of Pharmacology and Experimental Therapeutics, 291:409–415.Volkow ND y colab. (2001a) Low level of brain dopamine D2 receptors inmethamphetamine abusers: association with metabolism in the orbitofrontalcortex. American Journal of Psychiatry, 158:2015–2021.Volkow ND y colab. (2001b) Association of dopamine transporter reductionwith psychomotor impairment in methamphetamine abusers. American Journalof Psychiatry, 158:377–382.Von Euler G y colab. (1993) Persistent effects of subchronic toluene exposure onspatial learning and memory, dopamine-mediated locomotor activity anddopamine D2 agonist binding in the rat. Toxicology, 77:223–232.121
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASWang GJ y colab. (2000) Regional brain metabolism during alcohol intoxication.Alcoholism: Clinical and Experimental Research, 24:822–829.Weir E (2001) Inhalant use and addiction in Canada. Canadian MedicalAssociation Journal, 164:397.Weiss B, Wood RW, Macys DA (1979) Behavioral toxicology of carbon disulfideand toluene. Environmental Health Perspectives, 30:39–45.Wettstein JG, Gauthier B (1992) Discriminative stimulus effects of alprazolamand diazepam: generalization to benzodiazepines, antidepressants and buspirone.Behavioural Pharmacology, 3:229–237.OMS (1994) Lexicon of alcohol and drug terms. Ginebra, Organización Mundialde la Salud.OMS (1997a) Cannabis: a health perspective and research agenda. Ginebra,Organización Mundial de la Salud (documento WHO/MSA/PSA/97.4).OMS (1997b) Amphetamine-type stimulants: a report from the WHO Meeting onAmphetamines, MDMA and other Psychostimulants, Geneva, 12-15 November1996. Ginebra, Organización Mundial de la Salud. (documentoWHO/MSA/PSA/97.5).OMS (1998) Expert committee on drug dependence: thirtieth report. Ginebra,Organización Mundial de la Salud (Serie de Reportes Técnicos de la OMS, No. 873).OMS (1999) Volatile solvents abuse: a global overview. Ginebra, OrganizaciónMundial de la Salud (documento WHO/HSC/SAB/99.7).OMS (2001) Ecstasy: MDMA and other ring-substituted amphetamines Ginebra,Organización Mundial de la Salud (documento WHO/MSD/MSB/01.3).Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptationsmediating opioid dependence. Physiological Reviews, 81:299–343.Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction.Psychological Reviews, 94:469–492.Woolverton WL, Johnson KM (1992) Neurobiology of cocaine abuse. Trends inPharmacological Sciences, 13:193–200.Yavich L, Zvartau E (1994) A comparison of the effects of individual organic solventsand their mixture on brain stimulation reward. Pharmacology, Biochemistryand Behavior, 48:661–664.Yavich L, Patkina N, Zvartau E (1994) Experimental estimation of addictivepotential of a mixture of organic solvents. European Neuropsychopharmacology,4:111–118.Yui K y colab. (1999) Neurobiological basis of relapse prediction in stimulantinducedpsychosis and schizophrenia: the role of sensitization. MolecularPsychiatry, 4:512–523.122
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 88 and 89:
Capítulo 4Psicofarmacología de la
Page 90 and 91:
4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 92 and 93: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 146 and 147: Capítulo 5Bases Genéticas de lasF
Page 148 and 149: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 190 and 191: Capítulo 6Trastornos ConcurrentesI
Page 192 and 193:
6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195:
6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197:
6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199:
6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201:
6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203:
6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205:
6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207:
6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209:
6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211:
6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213:
6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215:
6. TRASTORNOS CONCURRENTESCarol G y
Page 216 and 217:
6. TRASTORNOS CONCURRENTESdepressio
Page 218 and 219:
6. TRASTORNOS CONCURRENTESHall RG y
Page 220 and 221:
6. TRASTORNOS CONCURRENTESKapur S,
Page 222 and 223:
6. TRASTORNOS CONCURRENTESMansvelde
Page 224 and 225:
6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227:
6. TRASTORNOS CONCURRENTESSevy S y
Page 228:
6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

Create successful ePaper yourself

Delete template?

Save as template?